Free-Up Bed Space
Adoption of Steripath can shorten length of stay by an average of 2 to 2.4 days3,4, opening up space for patients who need it most.
Increase Lab & PCR Capacity
Analysis of false positive blood cultures takes up critical lab and PCR processing capacity. Reduce this unnecessary testing burden and free up your resources.
Maximize Scarce Resources
False-positive results for sepsis lead to many wasted resources including PPE, provider time & focus, testing supplies & antibiotics.
COVID-19 Support Program
We're Here to Help!
Magnolia Medical is committed to helping ease the burden that the COVID-19 pandemic is placing on hospital staff and resources. To help, we are offering complimentary services and initial product during this time of crisis. Adopt Steripath now to immediately benefit from improved sepsis testing accuracy.
Current Customers will receive:
New Customers will receive:
Adopt the only FDA-cleared device indicated to reduce blood culture contamination5
- Zwang, O., et al. Journal of Hospital Medicine (2006)
- M. Rupp, et al; Reduction in Blood Culture Contamination Through Use of Initial Specimen Diversion Device. Clinical Infectious Diseases (August 2017)
Geisler BP et al., Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes, Journal of Hospital Infection, https://doi.org/10.1016/j.jhin.2019.03.012
Skoglund E, Dempsey CJ, Chen H, Garey KW. 2019. Estimated clinical and economic impact through use of a novel blood collection device to reduce blood culture contamination in the emergency department: a cost-benefit analysis. J Clin Microbiol 57:e01015-18. https://doi.org/10.1128/JCM .01015-18.
- Indicated to reduce blood culture contamination when contaminants are present, compared to standard method controls without diversion.